ASCLERA Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Asclera, and what generic alternatives are available?
Asclera is a drug marketed by Chemisch Fbrk Krsslr and is included in one NDA.
The generic ingredient in ASCLERA is polidocanol. Two suppliers are listed for this compound. Additional details are available on the polidocanol profile page.
Summary for ASCLERA
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 74 |
| Clinical Trials: | 1 |
| Patent Applications: | 2,864 |
| Formulation / Manufacturing: | see details |
| What excipients (inactive ingredients) are in ASCLERA? | ASCLERA excipients list |
| DailyMed Link: | ASCLERA at DailyMed |
Recent Clinical Trials for ASCLERA
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| UPECLIN HC FM Botucatu Unesp | Phase 4 |
| Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Pharmacology for ASCLERA
| Drug Class | Sclerosing Agent |
| Mechanism of Action | Sclerosing Activity |
| Physiological Effect | Vascular Sclerosing Activity |
Anatomical Therapeutic Chemical (ATC) Classes for ASCLERA
US Patents and Regulatory Information for ASCLERA
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chemisch Fbrk Krsslr | ASCLERA | polidocanol | SOLUTION;INTRAVENOUS | 021201-001 | Mar 30, 2010 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Chemisch Fbrk Krsslr | ASCLERA | polidocanol | SOLUTION;INTRAVENOUS | 021201-002 | Mar 30, 2010 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
